McKesson, the largest U.S. pharmaceutical distributor, continues to face obstacles as the tailwind from branded drug price inflation subsides and customers look elsewhere. But its management isn’t taking the news lying down. A series of acquisitions, ongoing restructuring, and a rash of new deals are helping lessen the blow, setting in motion a roller-coaster ride of a year. McKesson was founded in 1833 and is headquartered in San Francisco.
Looking for leads, investment insights, or competitive intelligence?
News about McKesson
The packets have a solution that neutralizes opioids.
Amazon is reportedly talking to drug firms.
Corporate governance matters, too.
New report highlights revolving door between DEA and industry.